For this analysis, eight recent individual price targets were reviewed. The most recent include Morgan Stanley at $5.01 (Sell, late October 2026), HSBC at $3.67 (Reduce, cut from $4.45 in late October), J.P. Morgan at $6.67 (Neutral, mid-October), Barclays at $11.00 (Hold, mid-October), RBC Capital at $4.45 (Hold, trimmed from $5.56 in mid-October), Freedom Broker at $6.80 (Buy, cut from $7.50 in mid-October), Jefferies at €8.00, or roughly $8.60 (Buy, late October), and Piper Sandler at $4.00 after a downgrade to Underweight. The arithmetic mean is about $6.28, which rounds to the $6.30 central target.
The dispersion is striking. Cautious analysts argue that a lagging product lineup, high U.S. inventories, and refinancing risk justify targets near or even below the current share price. More constructive voices, including Jefferies and Freedom Broker, emphasize a 2027 recovery, lower component costs feeding future launches, and free-cash-flow (FCF) inflection. S&P Global data points to a consensus rating of Hold, underscoring how split the Street is on the turnaround's timing.
Shares of Stellantis N.V. trade near $4.72, with a market capitalization of roughly $14 billion. Reaching $6.30 would require a move of about 33%—a substantial gain by any standard. The stock has fallen roughly 62% year-to-date and sits near the low end of a 52-week range of $3.92 to $12.22.
The company's third-quarter 2026 results were weak, with vehicle shipments down about 1.1% year over year, but management confirmed its 2027 outlook and pointed to positive FCF signals, which triggered an immediate double-digit rebound in the shares. Valuation remains deeply depressed: trailing earnings per share (EPS) are negative, while the stock trades at roughly 0.06 times sales and about 0.18 times book value. Whether the stock approaches $6.30 depends largely on whether investors begin to price in a genuine earnings recovery rather than further deterioration.
Several verified factors could support a recovery. The company is executing a product-line revamp and expanding its engineering team, while J.P. Morgan has highlighted lower component costs feeding FY2027 and FY2028 launches. A European Union–China agreement to roughly halve Chinese hybrid and plug-in-hybrid exports to Europe could ease competitive pressure in Stellantis' home market. Finally, the depressed multiple—near historic lows on a price-to-sales and price-to-book basis—means even modestly improved profitability could support a meaningful re-rating.
The obstacles are equally concrete. UBS and HSBC have flagged high U.S. dealer inventory and the potential need for price cuts or production adjustments. Morgan Stanley and Piper Sandler cite a lagging product pipeline, refinancing risk, and intensifying competition from Chinese brands and AI-focused rivals. Sluggish European demand, execution risk on the turnaround, and the possibility that earnings recovery slips further into the future could keep the shares range-bound or push them lower. The company is not currently paying a forward dividend, removing one traditional support for valuation.
The stock's long-term structure is firmly in a downtrend, trading well below its 52-week high of $12.22. The 52-week low of $3.92 stands as the key support level, with the $4.00 psychological round number just above it. On the upside, $5.00 is a nearby psychological resistance level, followed by a $6.00-to-$7.00 zone that previously acted as congestion. The $6.30 target sits within that broader resistance band, meaning the stock would likely need sustained fundamental improvement to push through it.
Analyst price targets generally reflect a research horizon of about 12 months, though individual firms differ in their assumptions. Investors should watch for the next quarterly earnings release, guidance for 2027, and any updates on shipments, FCF, U.S. inventory levels, and analyst rating or target revisions. Regulatory developments, including the EU–China trade arrangement and any tariff decisions, along with broader auto-sector demand, will also shape the path toward the target.
For traders seeking a more systematic view, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening allows. Given the volatility and wide analyst disagreement surrounding Stellantis, a data-driven signal system can offer a useful complement to fundamental research.
The $6.30 central target—an average of eight recent analyst price targets spanning roughly $3.67 to $11.00—implies a substantial, roughly 33% move from the current price near $4.72. The case for reaching it rests on a confirmed 2027 turnaround, positive free-cash-flow signals, product-line renewal, and an exceptionally low valuation. The case against it rests on high U.S. inventory, refinancing risk, a lagging pipeline, and fierce competition. The unusually wide analyst range shows that even professional forecasters disagree sharply on timing. Investors should monitor earnings, 2027 guidance, inventory, and analyst revisions rather than treat any single target as a certainty.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, STLA has been loosely correlated with F. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if STLA jumps, then F could also see price increases.
| Ticker / NAME | Correlation To STLA | 1D Price Change % | ||
|---|---|---|---|---|
| STLA | 100% | -1.04% | ||
| F - STLA | 50% Loosely correlated | +0.08% | ||
| GM - STLA | 43% Loosely correlated | -0.29% | ||
| RACE - STLA | 36% Loosely correlated | +1.39% | ||
| TM - STLA | 29% Poorly correlated | +1.31% | ||
| BLBD - STLA | 24% Poorly correlated | -0.04% | ||
More | ||||